Hospice care and survival among elderly patients with lung cancer

Journal of Palliative Medicine

Volumn 14, Issue 8, 2011, Pages 929-939

  Saito, Akiko M ^a   Landrum, Mary Beth ^b   Neville, Bridget A ^c   Ayanian, John Z ^b,d   Weeks, Jane C ^c   Earle, Craig C ^e  

^a NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e CANCER CARE ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER SURVIVAL; DEATH; DISEASE SURVEILLANCE; FEMALE; HOSPICE CARE; HUMAN; INSTRUMENTAL VARIABLE ANALYSIS; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROPENSITY SCORE; SOCIOECONOMICS; TERMINAL CARE; URBAN AREA;

AGED; DATABASES, FACTUAL; FEMALE; HOSPICE CARE; HUMANS; LUNG NEOPLASMS; MALE; SEER PROGRAM; SURVIVAL;

EID: 79961214379     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2010.0522     Document Type: Article

References (50)

1. Doyle D, Hanks G, MacDonald N (eds): Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press, 1998.
2. Jones AB, Moga DN, Davie KA: Transforming end-of-life care for the 21st century: The hospice vision. J Palliat Med 1999;2:9-14. (Pubitemid 29179859)
3. Smith TJ, Schnipper LJ: The American Society of Clinical Oncology program to improve end-of-life care. J Palliat Med 1998;1:221-230.
4. NHPCO Facts and Figures: Hospice Care in America (2009 Edition). www.nhpco.org/files/public/Statistics-Research/NHPCO-facts-and-figures.pdf. (Last accessed March 30, 2011).
5. Han B, Remsburg RE, McAuley WJ, Keay TJ, Travis SS: National trends in adult hospice use: 1991-1992 to 1999- 2000. Health Aff (Millwood) 2006;25:792-799. (Pubitemid 43824931)
6. Connor SR, Pyenson B, Fitch K, Spence C, Iwasaki K: Comparing hospice and nonhospice patient survival among patients who die within a three-year window. J Pain Symptom Manage 2007;33:238-246. (Pubitemid 46349540)
7. Kane RL, Wales J, Bernstein L, Leibowitz A, Kaplan S: A randomised controlled trial of hospice care. Lancet 1984;1: 890-894. (Pubitemid 14132397)
8. Temel JS, Greer JA, Muzikansky A, et al: Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010;363:733-742.
9. Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC: Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 2004;22:315-321. (Pubitemid 41095097)
10. Matsuyama R, Reddy S, Smith TJ: Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol 2006;24:3490-3496. (Pubitemid 46638908)
11. Gawande A. Letting Go. What should medicine do when it can't save your life? New Yorker, August 2, 2010. www newyorker.com/reporting/2010/08/02/ 100802fa-fact-gawande. (Last accessed March 30, 2011).
12. The Surveillance Research Program, NCI: SEER Registries: National Cancer Institute. http://seer.cancer.gov/registries/ data.html (Last accessed March 30, 2011).
13. Zippin C, Lum D, Hankey BF: Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 1995;76:2343-2350.
14. Nattinger AB, McAuliffe TL, Schapira MM: Generalizability of the surveillance, epidemiology, and end results registry population: Factors relevant to epidemiologic and health care research. J Clin Epidemiol 1997;50:939-945. (Pubitemid 27423524)
15. Centers for Medicare and Medicaid Services: U.S. Department of Health & Human Services. www.cms.gov/ (Last accessed March 30, 2011).
16. Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG: Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 1993;31: 732-748.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373-383. (Pubitemid 17055592)
18. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-619.
19. Klabunde CN, Potosky AL, Legler JM, Warren JL: Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000;53:1258-1267. (Pubitemid 32007842)
20. Makuc DM, Haglund B, Ingram DD, Kleinman JC, Feldman JJ: Health service areas for the United States. Vital Health Stat 2 1991:1-102.
21. Earle CC, Neville BA, Landrum MB, Souza JM, Weeks JC, Block SD, Grunfeld E, Ayanian JZ: Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care 2005;17:505-509. (Pubitemid 41762420)
22. Earle CC, Park ER, Lai B, Weeks JC, Ayanian JZ, Block S: Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol 2003;21:1133-1138. (Pubitemid 46594144)
23. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
24. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
25. Cox DR: Regression models and life tables [with discussion]. J R Stat Soc 1972;Series B:187-220.
26. Earle CC, Tsai JS, Gelber RD, Weinstein MC, Neumann PJ, Weeks JC: Effectiveness of chemotherapy for advanced lung cancer in the elderly: Instrumental variable and propensity analysis. J Clin Oncol 2001;19:1064-1070. (Pubitemid 32176282)
27. Christakis NA, Escarce JJ: Survival of Medicare patients after enrollment in hospice programs. N Engl J Med 1996;335:172-178. (Pubitemid 26249455)
28. Christakis NA, Iwashyna TJ: Impact of individual and market factors on the timing of initiation of hospice terminal care. Med Care 2000;38:528-541.
29. Connor SR, Elwert F, Spence C, Christakis NA: Geographic variation in hospice use in the United States in 2002. J Pain Symptom Manage 2007;34:277-285. (Pubitemid 47361670)
30. Iwashyna TJ, Chang VW, Zhang JX, Christakis NA: The lack of effect of market structure on hospice use. Health Serv Res 2002;37:1531-1551. (Pubitemid 36070253)
31. Miller SC, Weitzen S, Kinzbrunner B: Factors associated with the high prevalence of short hospice stays. J Palliat Med 2003;6:725-736. (Pubitemid 38435449)
32. Virnig BA, Kind S, McBean M, Fisher E: Geographic variation in hospice use prior to death. J Am Geriatr Soc 2000;48:1117-1125.
33. Rosenbaum PR, Rubin DB: The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41-55.
34. Parsons L: Reducing bias in a propensity score matched-pair sample using greedy matching techniques. In: Proceedings of the 25th Annual SAS Users Group International Conference. 2001:214-126.
35. Bowden RJ, Turkington DA: Instrumental Variables. Cambridge University Press: Cambridge, MA. 1984.
36. Landrum MB, Ayanian JZ: Causal effect of ambulatory specialty care on mortality following myocardial infarction: A comparison of propensity score and instrumental variable analyses. Health Serv Outcomes Res Method 2001;2:221-245.
37. McClellan M, McNeil BJ, Newhouse JP: Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA 1994;272:859-866. (Pubitemid 24282095)
38. Newhouse JP, McClellan M: Econometrics in outcomes research: The use of instrumental variables. Annu Rev Public Health 1998;19:17-34. (Pubitemid 28279922)
39. Stukel TA, Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ: Analysis of observational studies in the presence of treatment selection bias: Effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA 2007;297:278-285. (Pubitemid 46143305)
40. Greer DS, Mor V, Morris JN, Sherwood S, Kidder D, Birnbaum H: An alternative in terminal care: Results of the National Hospice Study. J Chronic Dis 1986;39:9-26. (Pubitemid 16150003)
41. Wallston KA, Burger C, Smith RA, Baugher RJ: Comparing the quality of death for hospice and non-hospice cancer patients. Med Care 1988;26:177-182.
42. Lackan NA, Ostir GV, Freeman JL, Mahnken JD, Goodwin JS: Decreasing variation in the use of hospice among older adults with breast, colorectal, lung, and prostate cancer. Med Care 2004;42:116-122.
43. Earle CC: Do unto others. J Clin Oncol 2006;24:3331-3332.
44. Emanuel EJ, Young-Xu Y, Levinsky NG, Gazelle G, Saynina O, Ash AS: Chemotherapy use among Medicare beneficiaries at the end of life. Ann Intern Med 2003;138:639-643.
45. Johnson KS, Kuchibhatla M, Tanis D, Tulsky JA: Racial differences in hospice revocation to pursue aggressive care. Arch Intern Med 2008;168:218-224. (Pubitemid 351185890)
46. Yancik R: Epidemiology of cancer in the elderly. Current status and projections for the future. Rays 1997;22(1 Suppl):3-9. (Pubitemid 27288048)
47. Thorpe KE, Howard D: Health insurance and spending among cancer patients. Health Aff (Millwood). 2003;Suppl Web Exclusives:W3-189-198.
48. McCarthy EP, Burns RB, Ngo-Metzger Q, Davis RB, Phillips RS: Hospice use among Medicare managed care and fee-forservice patients dying with cancer. JAMA 2003;289:2238-2245. (Pubitemid 37430192)
49. Riley GF, Potosky AL, Klabunde CN, Warren JL, Ballard- Barbash R: Stage at diagnosis and treatment patterns among older women with breast cancer: An HMO and fee-forservice comparison. JAMA 1999;281:720-726. (Pubitemid 29113453)
50. Whittle J, Steinberg EP, Anderson GF, Herbert R: Accuracy of Medicare claims data for estimation of cancer incidence and resection rates among elderly Americans. Med Care 1991;29:1226-1236.